Irvine, CA, United States of America

Ting-Bin Yu

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Ting-Bin Yu

Introduction

Ting-Bin Yu is a notable inventor based in Irvine, CA. He has made significant contributions to the field of cancer treatment and drug delivery systems. With a total of 2 patents, his work focuses on innovative formulations and methods that enhance therapeutic efficacy.

Latest Patents

One of Ting-Bin Yu's latest patents is titled "Use of umirolimus and its derivatives for treating cancer." This patent describes novel encapsulated umirolimus and umirolimus polymer conjugate formulations that exhibit enhanced permeability and retention at tumor sites. The methods provided in this patent aim to improve cancer treatment by administering these umirolimus formulations. Another significant patent is "Drug-containing bioabsorbable fibers and implants," which outlines methods for producing drug-containing bioabsorbable fibers. This patent also discloses methods for treating diseases using a bioabsorbable drug delivery device.

Career Highlights

Throughout his career, Ting-Bin Yu has worked with various companies, including Manli International Ltd. and Duning Incorporated. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Ting-Bin Yu has collaborated with notable individuals in his field, including Shih-Horng Su and Minh Nguyen. These collaborations have likely enriched his research and development efforts.

Conclusion

Ting-Bin Yu's contributions to the field of cancer treatment and drug delivery systems highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to advancing medical technology and enhancing patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…